TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: regional ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: regional perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: NIH Toolbox Flanker Inhibitory Control and Attention Test (% Correct)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: NIH Toolbox Dimensional Change Card Sort Test (% Correct)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: NIH Toolbox List Sorting Working Memory Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in RSV-specific serum neutralizing antibody (nAb) titers (GMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline in the composite autonomic symptom score COMPASS-31 for autonomic symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Active Stand Test of hemodynamic symptom parameters, exercise tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline of Six Minute Walk in hemodynamic parameters, exercise tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in mean score in Health-Related Quality of Life (QOL) SF-20
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Baseline Vessel Diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number of Participants with Medically Attended Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in feelings of depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Daily body weight gain between V1 and V3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fecal total pathogens load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Modified McKay's criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: American Society of Shoulder and Elbow Surgeons (ASES) Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Adherence and acceptability rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: EQ-5D-5L (EuroQol Group-5 dimensions-5 levels)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Gate speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade ≥3 toxicity associated with treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Six-minute pegboard and ring test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with treatment related adverse events (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: ipsilesional corticospinal excitability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Detection of allergens in human breast milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Role of breast milk in sensitization to allergens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Type 2 DM Self-Management Scale (SMS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of participants achieving Remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Erectile Function Evaluation Form (IIEF)
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Time to first relief of symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of diagnosed DIC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of undiagnosed DIC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: intracranial progression free survival (iPFS)
Endpoint domain: Mortality/survival
Primary endpoint: frequency of analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle Contraction Time (Tc)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cerebral Metabolic Rate of Oxygen (CMRO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cerebral Metabolic Rate of Glucose (CMRGlu)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concordance between RAD101 PET/MRI and MRI with macrocyclic gadolinium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression, anxiety and stress symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: time spent at the target glucose value (Time in range)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Participants Who Discontinue Study Intervention Due to an AE
Endpoint domain: Adverse events/effects
Primary endpoint: Balance and gait capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sway Directional Path (DP) anterior-posterior and medio-lateral
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sway Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain-derived neurotrophic factor (BDNF) biomarker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3 Min Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of individuals reporting Adverse Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of individuals reporting Serious Adverse Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of children assessed as having made a full recovery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Emotional Impact Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in Worst Itch Numeric Rating Scale (WI-NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biochemical recurrence-free survival (bRFS)
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants with Accurate Ultrasound Diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Health-Related Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cigarettes per day
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Child School Performance
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Change in arterial function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in local stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Data collection for gastrointestinal diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Difference in platelet counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percent of participants with clean drug screens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CIED infections
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability of the Peer Mentorship Program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Successful quit attempt
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients who request the self-sampled HPV test
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of patients who request the clinician-sampled test
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of patients who complete the self-sampled HPV test
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Post spinal anaesthesia hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall Response Rate (ORR) of Malignant Pleural Effusion (MPE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived odor intensity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of subjects with serum uric acid ≤360μmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Core temperature at hospital arrival
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of CART123 cells in combination with ruxolitinib
Endpoint domain: Adverse events/effects
Primary endpoint: CCI index on post operative day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: beat-by-beat arterial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: peripheral capillary oxygen saturation (SpO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: respiratory excursions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pain Behavior Scale (PBS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Radiation dose received by patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaginal Moisture Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Vaginal pH Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Positive effects
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of DLTs experienced
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Myocardial Infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain assessment after injections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Headache evaluation after injections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep quality evaluation after injections
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Number of sentinel lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Fluorescence signal-to-background ratio of the lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Dual-task cognitive performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Diagnostic accuracy of Fluorocholine PET/CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anterior posterior stability index (APSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall stability index (OASI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hematologic response VGPR or better rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion adherence to referral to specialized cardiovascular care in the intervention group
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion crossover to referral to specialized CV care in the control group
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Appropriateness Measure (AM)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of Intervention (FIM)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adapted Website Evaluation Questionnaire (WEQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Assessment of airway obstruction at attack and recovery visits using peak expiratory flow rate (PEFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Assessment of airway inflammation at attack and recovery visits using Fractional Exhaled Nitric Oxide (FeNO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Assessment of symptom burden at attack and recovery visits using the Acute AQLQ questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of acute radiation reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Adhesion of S. mutans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in awareness of iodine
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Liebowitz Social Anxiety Scale for Adults (LSAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Global Measure of Relationship Satisfaction (GMREL)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Global Measure of Sexual Satisfaction (GMSEX)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Quality of life associated with Chemotherapy Induced Peripheral Neuropathy
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Maximum Standardized uptake value (SUVmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Standardized Uptake Value (SUVmean) of liver
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ultrasound images of carotid artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants who discontinued study medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants compliant with study treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Composite of safety events
Endpoint domain: Adverse events/effects
Primary endpoint: Primary efficacy as assessed by primary patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of tegoprazan and tegoprazan's metabolite M1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of tegoprazan and tegoprazan's metabolite M1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: t1/2β of tegoprazan and tegoprazan's metabolite M1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants having nausea and vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of participants having diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of participants having increased gastric residual volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Vocal Codes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of immune tolerance participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of index ulcers healed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Diabetes Foot Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Foot Self-Care Behavior
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in lower extremity anaerobic performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evolution of hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Service Penetration (Effectiveness)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Average sleep duration on school days
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Daytime sleepiness on school days
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Changes in perceived management of stress
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ae
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Phonetic fluency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Flanker task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Closeness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total weight loss (TWL) in %
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Total Sleep Time at Week 8
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Number of Participants Who Experience One or More Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Participation rate in CRC screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Usability of a computerized system
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Functional differences between epithelial/basal cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differences in gene expression profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the basal and regulatory T-cell axis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: change in motor examination (MDS-UPDRS III) at 3 months postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in motor examination (MDS-UPDRS III) at 12 months postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in PD-related quality of life (PDQ-39)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Differentiation between females with LUTS and normal females
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Internal consistency of the ICIQ-FLUTS LF questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Test-retest reliability of the ICIQ-FLUTS LF questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Changes in Pulmonary function - FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in Pulmonary function - DLCO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: rate of viral infections
Endpoint domain: Adverse events/effects
Primary endpoint: Teed Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: O'Neill Grading System (OGS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone height changes around the implants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Well-Being Index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants with Nipah-specific antibody and neutralizing antibody responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Optimal length of shoulder muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: MAKE 90
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient reported lymphoedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients With Prescriptions of SGLT2i or GLP1-RA
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Length of Time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percent Completion
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Detection of microplastics in human heart tissue and blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with treatment-related death
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants with any type of stroke
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with myocardial infarction events
Endpoint domain: Adverse events/effects
Primary endpoint: Sleep levels
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in Difficulty in Emotion Regulation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Antrolith volume measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction in the severity or duration of CSAM use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 6-Minute Pegboard and Ring Test - Upper Extremity Functional Exercise Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Milliken Activities of Daily Living Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The Glittre Activities of Daily Living Test
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of vertigo attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee Injury and Osteoarthritis Outcome Score (KOOS) Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Visual Analogue Scale (VAS) at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone marrow suppression (Grade four)
Endpoint domain: Adverse events/effects